Development and validation of a reasons for electronic cigarette use questionnaire.
Experimental and Clinical Psychopharmacology · 2024
DOI: 10.1037/pha0000702 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Experimental and Clinical Psychopharmacology, 2024. Verfasst von David M Ledgerwood und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Neurosciences, School of Medicine, Wayne State University. Hauptthemen laut MEDLINE: Vaping, Electronic Nicotine Delivery Systems. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Gefördert von: State of Michigan, Detroit Wayne Integrated Health Network.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Neurosciences, School of Medicine, Wayne State University.
ORCID-Profile: David M Ledgerwood, Danishi K Bedi, Mannat K Bedi
Förderung
- State of Michigan
- Detroit Wayne Integrated Health Network
Zitieren
APA
Ledgerwood, D. M., Bedi, D. K., Bedi, M. K., Cannoy, C. N., Prakash, K., Foulon, A. E., Excell, S., & Lundahl, L. H. (2024). Development and validation of a reasons for electronic cigarette use questionnaire. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037/pha0000702
Vancouver
Ledgerwood DM, Bedi DK, Bedi MK, Cannoy CN, Prakash K, Foulon AE, et al. Development and validation of a reasons for electronic cigarette use questionnaire. Experimental and Clinical Psychopharmacology. 2024. doi:10.1037/pha0000702
BibTeX
@article{Ledgerwood2024,
author = {Ledgerwood, David M and Bedi, Danishi K and Bedi, Mannat K and Cannoy, Ciara N and Prakash, Krithika and Foulon, Alanna E and Excell, ShayLin and Lundahl, Leslie H},
title = {Development and validation of a reasons for electronic cigarette use questionnaire},
journal = {Experimental and Clinical Psychopharmacology},
year = {2024},
doi = {10.1037/pha0000702}
}
EUVIMED